It was investigated as a candidate obesity therapeutic but did not meet its primary endpoints in clinical trials, and no marketing approval followed
Invasive neurostimulation in stroke rehabilitation
Because AOD 9604 promotes weight loss without really affecting IGF-1 levels and insulin levels, it reduces the risk of developing glucose intolerance and other metabolic disorders
Cycle length 8 to 12 weeks on, 4 to 6 weeks off in common research community protocols
Martinod K, Witsch T, Farley K, Gallant M, Remold-ODonnell E, Wagner DD (2016) Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis
If you are a member of our Special Needs Plan, a prior authorization will be required to see out of network providers